See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / Lukas Schmidt

Author: Lukas Schmidt
05:26am, Monday, Mar 17, 2025
AstraZeneca Goes Big: $1 Billion Acquisition of EsoBiotec Set to Transform Cell Therapy Landscape
AstraZeneca (NASDAQ: AZN) plans to acquire EsoBiotec for up to $1 billion, enhancing its cell therapy capabilities in oncology and autoimmune disorders. The deal includes $425M upfront and $575M based on milestones, with potential market impacts for investors.
Read More